ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2014/10/23 | 2,100 | 2,124 | 2,073 | 2,103 | -16 | -0.8% | 141,700 |
2014/10/22 | 2,098 | 2,136 | 2,092 | 2,119 | +59 | +2.9% | 173,500 |
2014/10/21 | 2,066 | 2,088 | 2,050 | 2,060 | -6 | -0.3% | 170,200 |
2014/10/20 | 2,063 | 2,090 | 2,048 | 2,066 | +41 | +2% | 128,700 |
2014/10/17 | 2,024 | 2,084 | 2,024 | 2,025 | +12 | +0.6% | 183,600 |
2014/10/16 | 2,020 | 2,042 | 2,004 | 2,013 | -41 | -2% | 150,800 |
2014/10/15 | 2,080 | 2,095 | 2,030 | 2,054 | -23 | -1.1% | 157,100 |
2014/10/14 | 2,108 | 2,161 | 2,076 | 2,077 | -131 | -5.9% | 231,700 |
2014/10/10 | 2,164 | 2,237 | 2,164 | 2,208 | +7 | +0.3% | 170,800 |
2014/10/09 | 2,221 | 2,262 | 2,200 | 2,201 | -20 | -0.9% | 150,900 |
2014/10/08 | 2,197 | 2,281 | 2,163 | 2,221 | +21 | +1% | 324,500 |
2014/10/07 | 2,236 | 2,243 | 2,200 | 2,200 | -19 | -0.9% | 109,300 |
2014/10/06 | 2,209 | 2,248 | 2,207 | 2,219 | +23 | +1% | 82,500 |
2014/10/03 | 2,178 | 2,207 | 2,169 | 2,196 | +17 | +0.8% | 91,100 |
2014/10/02 | 2,241 | 2,248 | 2,175 | 2,179 | -81 | -3.6% | 149,400 |
2014/10/01 | 2,279 | 2,292 | 2,252 | 2,260 | -2 | -0.1% | 98,100 |
2014/09/30 | 2,308 | 2,310 | 2,243 | 2,262 | -43 | -1.9% | 162,400 |
2014/09/29 | 2,292 | 2,313 | 2,281 | 2,305 | +21 | +0.9% | 131,100 |
2014/09/26 | 2,320 | 2,323 | 2,277 | 2,284 | -89 | -3.8% | 223,700 |
2014/09/25 | 2,390 | 2,393 | 2,351 | 2,373 | -9 | -0.4% | 282,900 |
2014/09/24 | 2,388 | 2,390 | 2,372 | 2,382 | -6 | -0.3% | 167,700 |
2014/09/22 | 2,412 | 2,433 | 2,378 | 2,388 | -53 | -2.2% | 114,400 |
2014/09/19 | 2,379 | 2,450 | 2,360 | 2,441 | +79 | +3.3% | 298,300 |
2014/09/18 | 2,400 | 2,400 | 2,362 | 2,362 | -31 | -1.3% | 138,900 |
2014/09/17 | 2,380 | 2,400 | 2,380 | 2,393 | +8 | +0.3% | 82,700 |
2014/09/16 | 2,409 | 2,409 | 2,380 | 2,385 | -30 | -1.2% | 102,500 |
2014/09/12 | 2,426 | 2,439 | 2,410 | 2,415 | -10 | -0.4% | 103,100 |
2014/09/11 | 2,455 | 2,460 | 2,415 | 2,425 | -19 | -0.8% | 57,000 |
2014/09/10 | 2,409 | 2,448 | 2,409 | 2,444 | +33 | +1.4% | 64,400 |
2014/09/09 | 2,428 | 2,428 | 2,406 | 2,411 | +2 | +0.1% | 49,200 |
2014/09/08 | 2,420 | 2,424 | 2,400 | 2,409 | +3 | +0.1% | 88,500 |
2014/09/05 | 2,429 | 2,429 | 2,400 | 2,406 | -2 | -0.1% | 70,600 |
2014/09/04 | 2,452 | 2,453 | 2,404 | 2,408 | -55 | -2.2% | 189,600 |
2014/09/03 | 2,470 | 2,478 | 2,458 | 2,463 | -25 | -1% | 101,300 |
2014/09/02 | 2,504 | 2,507 | 2,479 | 2,488 | -21 | -0.8% | 98,500 |
2014/09/01 | 2,537 | 2,551 | 2,489 | 2,509 | -35 | -1.4% | 96,600 |
2014/08/29 | 2,509 | 2,565 | 2,509 | 2,544 | +30 | +1.2% | 83,100 |
2014/08/28 | 2,563 | 2,564 | 2,498 | 2,514 | -50 | -2% | 141,000 |
2014/08/27 | 2,553 | 2,582 | 2,553 | 2,564 | +17 | +0.7% | 83,200 |
2014/08/26 | 2,552 | 2,557 | 2,526 | 2,547 | -5 | -0.2% | 80,000 |
2014/08/25 | 2,539 | 2,557 | 2,493 | 2,552 | +57 | +2.3% | 83,500 |
2014/08/22 | 2,530 | 2,550 | 2,493 | 2,495 | -30 | -1.2% | 98,600 |
2014/08/21 | 2,490 | 2,526 | 2,477 | 2,525 | +44 | +1.8% | 65,900 |
2014/08/20 | 2,513 | 2,518 | 2,479 | 2,481 | -32 | -1.3% | 69,300 |
2014/08/19 | 2,470 | 2,524 | 2,470 | 2,513 | +52 | +2.1% | 112,700 |
2014/08/18 | 2,446 | 2,590 | 2,435 | 2,461 | +4 | +0.2% | 164,900 |
2014/08/15 | 2,446 | 2,464 | 2,440 | 2,457 | +21 | +0.9% | 34,900 |
2014/08/14 | 2,427 | 2,457 | 2,426 | 2,436 | +9 | +0.4% | 54,200 |
2014/08/13 | 2,424 | 2,440 | 2,415 | 2,427 | +3 | +0.1% | 57,000 |
2014/08/12 | 2,430 | 2,442 | 2,412 | 2,424 | -6 | -0.2% | 62,400 |
2651~
2700
件表示中 / 3772件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 203,000円 | +3.1% | -6.5% | 2.36% | 9.42倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 265,700円 | +21.7% | +999.9% | 0.00% | 12.24倍 | 4.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 312,500円 | +5.1% | -7.0% | 2.56% | 20.51倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 247,300円 | +4.1% | -3.1% | 2.35% | 21.48倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 151,400円 | -2.4% | -52.3% | 3.76% | 18.12倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム